Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis | Clinical Trials | Clareo Health

Back to search

COMPLETEDPhase 2/3

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

NCT03829917•Fundacion Nacional de Dermatologia

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Cutaneous Leishmaniasis, American

Interventions

Miltefosine and Paromomycin

miltefosine

+1 more

Locations

Bolivia

Locations (1)

Hopital, Dermatologico

Jorochito, SC, Bolivia

Key Dates

Start Date

February 1, 2019

Primary Completion Date

December 1, 2020

Completion Date

December 31, 2020

Last Updated

February 2, 2021

Sponsors

Lead Sponsor

Fundacion Nacional de Dermatologia

Collaborators

Hospital Dermatológico de Jorochito
Ministerio de Salud de Bolivia, Programa Nacional de Leishmaniasis
Alfred Berman Foundation

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2021Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions